O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+16.01%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$11.4B
AUM Growth
+$11.4B
(+11%)
Cap. Flow
-$84.1M
Cap. Flow
% of AUM
-0.74%
Top 10 Holdings %
Top 10 Hldgs %
35.43%
Holding
148
New
18
Increased
32
Reduced
23
Closed
13
Top Buys
| 1 |
Boston Scientific
BSX
|
$234M |
| 2 |
ACT.PRA
ACTAVIS PLC PFD CONV SER A (IRL)
ACT.PRA
|
$105M |
| 3 |
Bristol-Myers Squibb
BMY
|
$77M |
| 4 |
BLUE
bluebird bio
BLUE
|
$66.5M |
| 5 |
Cardinal Health
CAH
|
$57.3M |
Top Sells
| 1 |
Vertex Pharmaceuticals
VRTX
|
$188M |
| 2 |
AGN
ALLERGAN INC
AGN
|
$158M |
| 3 |
Merck
MRK
|
$144M |
| 4 |
Biogen
BIIB
|
$122M |
| 5 |
NPSP
NPS PHARMACEUTICALS INC
NPSP
|
$106M |
Sector Composition
| 1 | Healthcare | 85.68% |
| 2 | Technology | 0.16% |
| 3 | Financials | 0.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Agilent Technologies
A
$35.7B
| $168M | 1.44% | 4,051,000 | – | – |
|
27
McKesson
MCK
$85.4B
| $161M | 1.38% | 713,000 -29,000 | -4% | -$6.56M |
|
28
Zimmer Biomet
ZBH
$21B
| $144M | 1.23% | 1,228,000 -54,700 | -4% | -$6.43M |
|
|
TRNX
29
DELISTED
TORNIER N V SHARES (NLD)
TRNX
| $126M | 1.08% | 4,805,000 | – | – |
|
|
TSRO
30
DELISTED
TESARO, Inc.
TSRO
| $118M | 1.01% | 2,057,700 +727,700 | +55% | +$41.8M |
|
|
ESRX
31
DELISTED
Express Scripts Holding Company
ESRX
| $116M | 0.99% | 1,333,000 -974,000 | -42% | -$84.5M |
|
|
ACT.PRA
32
DELISTED
ACTAVIS PLC PFD CONV SER A (IRL)
ACT.PRA
| $105M | 0.9% | +104,200 | New | +$105M |
|
33
Pfizer
PFE
$141B
| $104M | 0.89% | 2,984,000 +225,000 | +8% | +$7.83M |
|
34
Stryker
SYK
$150B
| $103M | 0.88% | 1,113,000 +81,400 | +8% | +$7.51M |
|
|
MGLN
35
DELISTED
Magellan Health Services, Inc.
MGLN
| $100M | 0.86% | 1,414,800 +206,800 | +17% | +$14.6M |
|
|
MNK
36
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $100M | 0.86% | 791,001 +224,000 | +40% | +$28.4M |
|
|
ALXN
37
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $98M | 0.84% | 565,700 +233,700 | +70% | +$40.5M |
|
|
AFFX
38
DELISTED
AFFYMETRIX INC
AFFX
| $92.3M | 0.79% | 7,351,000 +783,000 | +12% | +$9.83M |
|
39
Standard BioTools
LAB
$481M
| $89.9M | 0.77% | 2,136,200 | – | – |
|
40
Puma Biotechnology
PBYI
$254M
| $87.4M | 0.75% | 370,200 +119,300 | +48% | +$28.2M |
|
|
41
Cardinal Health
CAH
$35.5B
| $86.7M | 0.74% | 960,000 +635,000 | +195% | +$57.3M |
|
|
OTIC
42
DELISTED
Otonomy, Inc.
OTIC
| $79.8M | 0.68% | 2,256,398 | – | – |
|
|
ISEE
43
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $77.6M | 0.66% | 1,668,600 +806,800 | +94% | +$37.5M |
|
|
CLVS
44
DELISTED
Clovis Oncology, Inc.
CLVS
| $74.3M | 0.63% | 1,000,400 +286,300 | +40% | +$21.3M |
|
|
INSY
45
DELISTED
Insys Therapeutics, Inc.
INSY
| $72.3M | 0.62% | 1,243,200 | – | – |
|
|
ARRY
46
DELISTED
Array Biopharma Inc
ARRY
| $68M | 0.58% | 9,232,310 +1,984,610 | +27% | +$14.6M |
|
47
Teva Pharmaceuticals
TEVA
$21.1B
| $68M | 0.58% | 1,091,000 +691,000 | +173% | +$43M |
|
48
Insulet
PODD
$23.9B
| $66.6M | 0.57% | 1,997,000 | – | – |
|
|
BLUE
49
DELISTED
bluebird bio
BLUE
| $66.5M | 0.57% | +550,700 | New | +$66.5M |
|
|
WMGI
50
DELISTED
Wright Medical Group Inc
WMGI
| $65.2M | 0.56% | 2,527,000 | – | – |
|